Finnegan Neonatal Abstinence Scoring Tool (FNAST)
21-item scoring system assessing severity of neonatal abstinence syndrome (NAS) in neonates born to mothers using opioids or other substances. Scored every 3–4 hours. Total score guides pharmacological treatment initiation and weaning.
Score interpretation
Finnegan score below 8
→ Non-pharmacological care: swaddling, reduced stimulation, skin-to-skin contact, small frequent feeds, breastfeeding if appropriate and safe; continue 3–4 hourly scoring; involve social work if maternal substance use ongoing
Score ≥ 8: pharmacological treatment is indicated if three consecutive scores are ≥ 8
→ Rescore every 3–4 hours; neonatal team review; start pharmacological treatment per local protocol if three consecutive scores are ≥ 8; continue non-pharmacological measures
Score ≥ 12: pharmacological treatment is indicated if two consecutive scores are ≥ 12
→ Rescore promptly; neonatologist review; start pharmacological treatment per local protocol (oral morphine per a children's formulary) if two consecutive scores are ≥ 12; NICU/SCN admission; safeguarding
Interpretation bands for the Finnegan NAS Score. Apply clinical judgement and local guidance.
References
- Finnegan LP et al. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1–2):141–158.
- Gomez Pomar E, Finnegan LP, et al. Simplification of the Finnegan Neonatal Abstinence Scoring System. BMJ Open. 2017;7:e016176.
Related
Curated clinical cross-links plus same-class fallbacks.
- Poractant Alfa (Porcine Surfactant) · Lung Surfactant (Respiratory Distress Syndrome — Neonatal)
- Clonidine · Alpha-2 Adrenoceptor Agonist (ADHD / Opioid Withdrawal / Tic Disorders)
- Remifentanil · Opioid (Ultra-Short-Acting)
- Phenylephrine · Alpha-1 Adrenergic Agonist (Pure Vasoconstrictor)
- Morphine (IV/IM — Anaesthesia/ICU) · Strong Opioid Analgesic
- Alfentanil · Opioid Analgesic (Ultra-Short Acting)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.